Use of intrauterine devices/implants and injectables under the universal health coverage scheme in Indonesia

Background/Aims Family planning services are crucial for improving maternal and child health, reducing unintended pregnancies and enhancing wellbeing. Indonesia's universal health coverage programme has increased access to these services, but use varies widely. This study explored the use of intrauterine devices/implants and injectables under the universal health coverage programme using a national dataset from 2021. Methods This cross-sectional study was conducted using secondary data from the Indonesian Social Health Insurance Administration. The sample included 7855 married couples aged 15–49 years. Binary logistic regression was used to analyse factors influencing use of intrauterine devices/implants and injectables. Results Most users (60.2%) were premium assistance beneficiaries who received government subsidies for healthcare services. Informal workers (who did not receive subsidies) (P<0.001), those aged 21–35 years (P<0.001) and those registered with network providers (P<0.001) were more likely to use injectables. Conclusions Optimising universal health coverage for family planning services and enhancing promotional efforts are essential to encourage engagement across all universal health coverage members. Implications for practice Tailoring Indonesia's family planning services to account for demographic needs could improve equitable access and increase contraceptive uptake.